Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.

Yeung, Carrie; Petrella, Teresa M; Wright, Frances; Abadir, Wadid; Look Hong, Nicole J

doi:10.1080/1744666X.2017.1286984

Record: found
Abstract: found
Article: not found

Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.

Author(s): Carrie Yeung ¹ , Teresa M Petrella ² , Frances C Wright ³ , Wadid Abadir ⁴ , Nicole J Look Hong ³

Publication date (Electronic): Apr 2017

Journal: Expert review of clinical immunology

Publisher: Informa UK Limited

Keywords: Diphencyprone, immunotherapy, in-transit metastasis, melanoma, toxicity

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Diphencycprone (DPCP) is an immune contact sensitizer applied to melanoma lesions. Early studies show favorable efficacy. We present the first North-American series of patients treated with DPCP.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Expert Rev Clin Immunol

Title: Expert review of clinical immunology

Publisher: Informa UK Limited

ISSN (Electronic): 1744-8409

ISSN (Print): 1744-666X

Publication date (Electronic): Apr 2017

Volume: 13

Issue: 4

Affiliations

[1 ] a Division of Medical Oncology , University of Toronto , Toronto , ON , Canada.

[2 ] b Division of Medical Oncology , Sunnybrook Health Sciences Centre , Toronto , ON , Canada.

[3 ] c Division of Surgical Oncology, Sunnybrook Health Sciences Centre , University of Toronto , Toronto , ON , Canada.

[4 ] d Division of Dermatology , University of Toronto , Toronto , ON , Canada.

Article

DOI: 10.1080/1744666X.2017.1286984

PubMed ID: 28121191

SO-VID: 3f876f43-53d1-4f40-9715-4764d31280fc

History

Keywords: Diphencyprone,immunotherapy,in-transit metastasis,melanoma,toxicity

Data availability:

Keywords: Diphencyprone, immunotherapy, in-transit metastasis, melanoma, toxicity

Topical immunotherapy with diphencyprone (DPCP) for in-transit and unresectable cutaneous melanoma lesions: an inaugural Canadian series.

Read this article at

Abstract

Related collections

Cancer Immunotherapy

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 25

Cited by 7